Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 04 - 09    symbols : SNY    save search

Sanofi Snatches Up Tidal Therapeutics in $470 Deal
Published: 2021-04-09 (Crawled : 20:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

therapeutics
Sanofi Snatches Up Tidal Therapeutics in $470 Million Deal
Published: 2021-04-09 (Crawled : 20:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

therapeutics
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
Published: 2021-04-09 (Crawled : 18:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

disease immunology research application
Outlook on the Pharmaceutical Manufacturing Global Market to 2027 - Trend Forecast and Growth Opportunities
Published: 2021-04-09 (Crawled : 17:00) - prnewswire.com
PFE | News A | $26.26 1.0% -0.08% 36M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 2.53% C: 1.95%
NVS | News | $95.12 0.81% -1.18% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 0.6% C: 0.45%
JNJ | News | $149.12 0.82% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 0.5% C: -0.54%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 0.87% C: 0.83%
LLY | News | $731.33 0.69% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 1.43% C: 1.07%
ABT | News | $107.07 -0.2% 0.0% 4.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 1.07% C: 1.04%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

growth
Outlook on the Antisense & RNAi Therapeutics Global Market to 2030 - COVID-19 Growth and Change
Published: 2021-04-09 (Crawled : 16:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%
MRNA | News S | $104.48 3.03% 2.94% 3.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 7.86% C: 5.55%
IONS | $41.08 0.98% 0.97% 670K twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 1.13% C: -0.33%
BIIB | $194.1 -0.14% -0.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.08% C: 0.92%
ARWR | $23.94 7.21% 6.73% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 0.08% C: -1.66%
ALNY | $145.78 0.95% 0.94% 390K twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.26% C: -2.61%

covid growth covid-19
NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression
Published: 2021-04-09 (Crawled : 13:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%
REGN | News | $899.71 0.32% 0.32% 340K twitter stocktwits trandingview |
Health Technology
| | O: -0.03% H: 0.85% C: -0.22%

covid treatment risk casirivimab
Hansa Biopharma: Notice to Annual General Meeting - Apr 09, 2021
Published: 2021-04-09 (Crawled : 10:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

biopharma
Evotec And Exscientia Announce Start of Human Clinical Trials of Novel Immuno-Oncology Drug
Published: 2021-04-09 (Crawled : 10:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

clinical trials drug trial
Hansa Biopharma: Notice to Annual General Meeting
Published: 2021-04-09 (Crawled : 07:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%

biopharma
Kiadis employee options committed under the Sanofi Offer
Published: 2021-04-09 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%


Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi’s novel investigational IL-2
Published: 2021-04-09 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.79% C: 0.57%


Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a

EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a

ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a

VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.